Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair Journal Article


Authors: Rotolo, J. A.; Fong, C. S.; Bodo, S.; Nagesh, P. K. B.; Fuller, J.; Sharma, T.; Piersigilli, A.; Zhang, Z.; Fuks, Z.; Singh, V. K.; Kolesnick, R.
Article Title: Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair
Abstract: After 9/11, threat of nuclear attack on American urban centers prompted government agencies to develop medical radiation countermeasures to mitigate hematopoietic acute radiation syndrome (H-ARS) and higher-dose gastrointestinal acute radiation syndrome (GI-ARS) lethality. While repurposing leukemia drugs that enhance bone marrow repopulation successfully treats H-ARS in preclinical models, no mitigator potentially deliverable under mass casualty conditions preserves GI tract. Here, we report generation of an anti-ceramide 6B5 single-chain variable fragment (scFv) and show that s.c. 6B5 scFv delivery at 24 hours after a 90% lethal GI-ARS dose of 15 Gy mitigated mouse lethality, despite administration after DNA repair was complete. We defined an alternate target to DNA repair, an evolving pattern of ceramide-mediated endothelial apoptosis after radiation, which when disrupted by 6B5 scFv, initiates a durable program of tissue repair, permitting crypt, organ, and mouse survival. We posit that successful preclinical development will render anti-ceramide 6B5 scFv a candidate for inclusion in the Strategic National Stockpile for distribution after a radiation catastrophe. © 2021, Rotolo et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Journal Title: JCI Insight
Volume: 6
Issue: 8
ISSN: 2379-3708
Publisher: Amer Soc Clinical Investigation Inc  
Date Published: 2021-04-22
Start Page: e145380
Language: English
DOI: 10.1172/jci.insight.145380
PUBMED: 33724956
PROVIDER: scopus
PMCID: PMC8119204
DOI/URL:
Notes: Article -- Export Date: 1 June 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Zhigang Zhang
    427 Zhang
  2. Zvi Fuks
    427 Fuks
  3. Richard N Kolesnick
    298 Kolesnick
  4. Chii Shyang Fong
    10 Fong
  5. Jimmy A Rotolo
    35 Rotolo
  6. John David Fuller
    11 Fuller
  7. Sahra Bodo
    5 Bodo
  8. Thivashnee Sharma
    1 Sharma